Cargando…

Impact of respiratory syncytial virus in an open bay neonatal intensive care unit

Background: Respiratory syncytial virus, RSV, is a respiratory virus that causes cold-like symptoms in adults. In infants and young children, RSV can cause severe illnesses such as bronchiolitis or pneumonia. We describe a successful response to a laboratory-confirmed RSV outbreak in a 21-bed open-p...

Descripción completa

Detalles Bibliográficos
Autores principales: Morris, Minisha, Vasandani, Annette, Estrada, Yvonne, Merchant, Malik, Garcia, Annie, Duran, John, Gallant, Melissa, Benesh, Adonica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10594330/
http://dx.doi.org/10.1017/ash.2023.360
_version_ 1785124625418551296
author Morris, Minisha
Vasandani, Annette
Estrada, Yvonne
Merchant, Malik
Garcia, Annie
Duran, John
Gallant, Melissa
Benesh, Adonica
author_facet Morris, Minisha
Vasandani, Annette
Estrada, Yvonne
Merchant, Malik
Garcia, Annie
Duran, John
Gallant, Melissa
Benesh, Adonica
author_sort Morris, Minisha
collection PubMed
description Background: Respiratory syncytial virus, RSV, is a respiratory virus that causes cold-like symptoms in adults. In infants and young children, RSV can cause severe illnesses such as bronchiolitis or pneumonia. We describe a successful response to a laboratory-confirmed RSV outbreak in a 21-bed open-pod neonatal intensive care unit (NICU) at a level 2 trauma hospital. Methods: After 2 of the 3 initial neonates were diagnosed with hospital-onset RSV, an outbreak investigation began on November 16, 2022. Following the results, testing was expanded to all neonates in the NICU. The clinical case was defined as a hospitalized neonate with laboratory confirmation of RSV by RSV antigen screen or polymerase chain reaction (PCR) detection on the Biofire respiratory panel. Outbreak resolution was determined by utilizing a viral test for the remaining positive neonates after the 2-week incubation period from the last identified positive neonate. Results: On day 1 of the investigation, 6 of 18 neonates were identified as positive for RSV. The initial 12 negative neonates received a prophylactic dose of palivizumab. Due to the increase in positive neonates, enhanced infection prevention and control measures were immediately implemented. These measures included the immediate closure of the NICU for new transfers, placing all positive neonates in a single-bay cohort in the NICU, implementing contact and droplet precautions, minimizing shared staff, increasing environmental cleaning, and using dedicated equipment. With awareness of the increased community occurrence of RSV, additional measures were taken to monitor adherence to infection prevention and control measures by staff and visitors entering the NICU, including daily symptom screening. Visitation was restricted to block scheduling to monitor the number of individuals in the NICU. Once we obtained the complete conversion of the initial neonate cohort, the additional focus shifted to maintaining the enhanced precautions until all neonate laboratory tests were negative. The NICU was successfully reopened once the remaining 3 positive neonates received no growth on their viral culture. Conclusions: The quick and effective response from a multidisciplinary team allowed a successful intervention to mitigate the identified outbreak. This investigation highlights the importance of enhanced infection prevention and control practices during increased community spread. Future efforts focus on educating staff and visitors on appropriate measures to decrease transmission risks. Disclosures: None
format Online
Article
Text
id pubmed-10594330
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-105943302023-10-25 Impact of respiratory syncytial virus in an open bay neonatal intensive care unit Morris, Minisha Vasandani, Annette Estrada, Yvonne Merchant, Malik Garcia, Annie Duran, John Gallant, Melissa Benesh, Adonica Antimicrob Steward Healthc Epidemiol Outbreaks Background: Respiratory syncytial virus, RSV, is a respiratory virus that causes cold-like symptoms in adults. In infants and young children, RSV can cause severe illnesses such as bronchiolitis or pneumonia. We describe a successful response to a laboratory-confirmed RSV outbreak in a 21-bed open-pod neonatal intensive care unit (NICU) at a level 2 trauma hospital. Methods: After 2 of the 3 initial neonates were diagnosed with hospital-onset RSV, an outbreak investigation began on November 16, 2022. Following the results, testing was expanded to all neonates in the NICU. The clinical case was defined as a hospitalized neonate with laboratory confirmation of RSV by RSV antigen screen or polymerase chain reaction (PCR) detection on the Biofire respiratory panel. Outbreak resolution was determined by utilizing a viral test for the remaining positive neonates after the 2-week incubation period from the last identified positive neonate. Results: On day 1 of the investigation, 6 of 18 neonates were identified as positive for RSV. The initial 12 negative neonates received a prophylactic dose of palivizumab. Due to the increase in positive neonates, enhanced infection prevention and control measures were immediately implemented. These measures included the immediate closure of the NICU for new transfers, placing all positive neonates in a single-bay cohort in the NICU, implementing contact and droplet precautions, minimizing shared staff, increasing environmental cleaning, and using dedicated equipment. With awareness of the increased community occurrence of RSV, additional measures were taken to monitor adherence to infection prevention and control measures by staff and visitors entering the NICU, including daily symptom screening. Visitation was restricted to block scheduling to monitor the number of individuals in the NICU. Once we obtained the complete conversion of the initial neonate cohort, the additional focus shifted to maintaining the enhanced precautions until all neonate laboratory tests were negative. The NICU was successfully reopened once the remaining 3 positive neonates received no growth on their viral culture. Conclusions: The quick and effective response from a multidisciplinary team allowed a successful intervention to mitigate the identified outbreak. This investigation highlights the importance of enhanced infection prevention and control practices during increased community spread. Future efforts focus on educating staff and visitors on appropriate measures to decrease transmission risks. Disclosures: None Cambridge University Press 2023-09-29 /pmc/articles/PMC10594330/ http://dx.doi.org/10.1017/ash.2023.360 Text en © The Society for Healthcare Epidemiology of America 2023 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Outbreaks
Morris, Minisha
Vasandani, Annette
Estrada, Yvonne
Merchant, Malik
Garcia, Annie
Duran, John
Gallant, Melissa
Benesh, Adonica
Impact of respiratory syncytial virus in an open bay neonatal intensive care unit
title Impact of respiratory syncytial virus in an open bay neonatal intensive care unit
title_full Impact of respiratory syncytial virus in an open bay neonatal intensive care unit
title_fullStr Impact of respiratory syncytial virus in an open bay neonatal intensive care unit
title_full_unstemmed Impact of respiratory syncytial virus in an open bay neonatal intensive care unit
title_short Impact of respiratory syncytial virus in an open bay neonatal intensive care unit
title_sort impact of respiratory syncytial virus in an open bay neonatal intensive care unit
topic Outbreaks
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10594330/
http://dx.doi.org/10.1017/ash.2023.360
work_keys_str_mv AT morrisminisha impactofrespiratorysyncytialvirusinanopenbayneonatalintensivecareunit
AT vasandaniannette impactofrespiratorysyncytialvirusinanopenbayneonatalintensivecareunit
AT estradayvonne impactofrespiratorysyncytialvirusinanopenbayneonatalintensivecareunit
AT merchantmalik impactofrespiratorysyncytialvirusinanopenbayneonatalintensivecareunit
AT garciaannie impactofrespiratorysyncytialvirusinanopenbayneonatalintensivecareunit
AT duranjohn impactofrespiratorysyncytialvirusinanopenbayneonatalintensivecareunit
AT gallantmelissa impactofrespiratorysyncytialvirusinanopenbayneonatalintensivecareunit
AT beneshadonica impactofrespiratorysyncytialvirusinanopenbayneonatalintensivecareunit